Survival outcomes and influencing factors in patients with metastatic castration resistant prostate cancer treated with abiraterone acetate or enzalutamide

doi:10.3969/j.issn.1672-3384.2024.10.006

Hongtao CHENG, Zhongxiao LI, Luna ZHENG, Yuhong LI

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (10) : 27-32.

PDF(648 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (10) : 27-32. DOI: 10.3969/j.issn.1672-3384.2024.10.006

Original Article

Survival outcomes and influencing factors in patients with metastatic castration resistant prostate cancer treated with abiraterone acetate or enzalutamide

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(10): 27-32 https://doi.org/10.3969/j.issn.1672-3384.2024.10.006

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(648 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-08-07	2024-10-20
Issue Date
2024-12-25

Please choose a citation manager

Content to export